Sheridan John F reported option exercise involving 9,934 shares of TANDEM DIABETES CARE INC at $0.00 for $0 on Aug 15, 2026

Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
PRESIDENT & CEO
PRESIDENT & CEO
Filed Aug 18, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
$0Shares × reported price
Shares traded
9,934Common Stock
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
165,315Direct
Trade date
Aug 15, 2026Option exercise
Filed
Aug 18, 2026, 4:28 PM ET3-day reporting delay
Accession
0001438133-26-000131Code M · Transaction 2508
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Aug 15, 2026Tax withholding3,044$22.72−$69,159.68Trade 2507
Aug 15, 2026Tax withholding5,055$22.72−$114,849.60Trade 2509
Aug 15, 2026Option exercise5,982$0.00$0Trade 2510
Aug 15, 2026Option exercise9,934$0.00$0Trade 2511
Aug 15, 2026Option exercise5,982$0.00$0Trade 2506
6 transaction rows in this filing. Joint filers share the same rows.

TNDM price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
TNDM · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago −34%1w ago −15%1d ago −15%
Returns since7d −9.1%30d −27%90d −22%180d1y

Footnotes in full

F1: Shares withheld by the Issuer to satisfy tax withholding requirements upon the vesting of restricted stock units (RSUs). No shares were sold. F2: Awarded on May 23, 2024 pursuant to the Tandem Diabetes Care Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan). F3: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan. F4: One-third of the RSUs granted on May 23, 2024 vested on May 15, 2025, with the remaining RSUs vesting in eight (8) equal quarterly installments thereafter, subject to the terms of the 2023 Plan. F5: Awarded on May 30, 2025 pursuant to the 2023 Plan. F6: One-third of the RSUs granted on May 30, 2025 vested on May 15, 2026, with the remaining RSUs vesting in eight (8) equal quarterly installments thereafter, subject to the terms of the 2023 Plan.